Testing effectiveness (Phase 2)Study completedNCT03099187
What this trial is testing
Pirfenidone in Patients With Unclassifiable Progressive Fibrosing Interstitial Lung Disease
Who this might be right for
Lung Diseases, Interstitial
Hoffmann-La Roche 253